High expression of KNL1 in prostate adenocarcinoma is associated with poor prognosis and immune infiltration
Frontiers in Genetics · 06.01.2023 · 13
DOI: 10.3389/fgene.2022.1100787 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Genetics, online erschienen am 06.01.2023. Verfasst von Yetao Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Prostate adenocarcinoma (PRAD) is a common malignancy with increasing morbidity and mortality. Kinetochore scaffold 1 (KNL1) has been reported to be involved in tumor progression and prognosis in other tumors, but its role in PRAD has not been reported in detail. KNL1 expression analysis, clinicopathological parameters analysis, prognostic correlation analysis, molecular interaction network and functional abdominal muscle analysis and immune infiltration analysis by using multiple online databases and downloaded expression profile. The results suggest that KNL1 is highly expressed in PRAD, which is associated with worse prognosis in PRAD patients. KnL1-related genes are highly enriched in mitotic function, which is considered to be highly related to the development of cancer. Finally, KNL1 expression is associated with a variety of tumor infiltrating immune cells, especially Treg and Th2 cells. In conclusion, our findings provide preliminary evidence that KNL1 may be an independent prognostic predictor of PRAD and is associated with immune infiltration.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
- Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
Zitieren
APA
Zhang, Y., Ji, Q., Wang, J., Dong, Y., Pang, M., Fu, S., Wei, Y., & Zhu, Q. (2023). High expression of KNL1 in prostate adenocarcinoma is associated with poor prognosis and immune infiltration. Frontiers in Genetics, 13. https://doi.org/10.3389/fgene.2022.1100787
Vancouver
Zhang Y, Ji Q, Wang J, Dong Y, Pang M, Fu S, et al. High expression of KNL1 in prostate adenocarcinoma is associated with poor prognosis and immune infiltration. Frontiers in Genetics. 2023;13. doi:10.3389/fgene.2022.1100787
BibTeX
@article{Zhang2023,
author = {Zhang, Yetao and Ji, Qianying and Wang, Jun and Dong, Yuxiang and Pang, Mingyang and Fu, Shengqiang and Wei, Yong and Zhu, Qingyi},
title = {High expression of KNL1 in prostate adenocarcinoma is associated with poor prognosis and immune infiltration},
journal = {Frontiers in Genetics},
year = {2023},
volume = {13},
doi = {10.3389/fgene.2022.1100787}
}
EUVIMED